We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HVT:NYSEHaverty Furniture Companies, Inc. Analysis

Data as of 2026-05-24 - not real-time

$22.35

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Haverty Furniture posted a solid Q1 top‑line beat, with net sales rising 4.1% YoY to $189.1 M and comparable sales up 4.3% for a third straight quarter. Management highlighted higher average ticket sizes, expanding design‑service revenue and a robust 2026 store pipeline, while gross margins are projected to stay near the 60.5‑61% range despite tariff and fuel‑cost headwinds. However, the stock trades at $22.35, well above the DCF‑derived fair value of $9.20 and just under its 200‑day SMA of $23.00, signalling a bearish technical stance. The dividend yield looks attractive at 5.9%, but the payout ratio exceeds 100%, raising concerns about sustainability. With a 30‑day volatility of 37% and a beta around 1.05, the equity is more volatile than the market, and its low ROE (6.6%) and thin operating margin (2.6%) limit upside potential.
Given the over‑extended valuation, unsustainable dividend policy, and bearish price dynamics, the near‑term outlook remains cautious despite the positive earnings momentum.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish technical trend (price below SMA‑200 and SMA‑20)
  • Overvaluation relative to DCF fair value
  • Dividend payout ratio >100% (unsustainable)

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Positive earnings momentum and comparable‑sales growth
  • Stable gross margins near 61%
  • High volatility and beta indicating price swings

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Potential turnaround from store expansion and design‑service initiatives
  • Improving cash flow generation (operating cash flow > free cash flow)
  • Long‑term value perception if dividend policy is restructured

Key Metrics & Analysis

Financial Health

Revenue Growth4.10%
Profit Margin2.64%
P/E Ratio18.3
ROE6.61%
ROA2.20%
Debt/Equity71.50
P/B Ratio1.2
Op. Cash Flow$43.6M
Free Cash Flow$16.7M

Technical Analysis

TrendBearish
RSI56.5
Support$20.10
Resistance$22.94
MA 20$21.51
MA 50$21.72
MA 200$23.00
MACDBullish
VolumeStable
Fear & Greed Index91.61

Valuation

Fair Value$9.20
Target Price$29.50
Upside/Downside31.99%
GradeOvervalued
TypeValue
Dividend Yield5.91%

Risk Assessment

Beta1.05
Volatility37.05%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.